Recently however, a new oxaborole inhibitor, DS86760016, has reignited the re-use of the LeuRS inhibitor resulting in a lower frequency of resistance development than ETB in comparative murine urinary tract infection models. The gene discussed is LARS1; the disease is urinary tract infection.